The aim of this study was to describe the prevalence and patterns of neuropathic pain over one year in a cohort of patients with chronic post-surgical pain at three months following total knee arthroplasty (TKA). Between 2016 and 2019, 363 patients with troublesome pain, defined as a score of ≤ 14 on the Oxford Knee Score pain subscale, three months after TKA from eight UK NHS hospitals, were recruited into the Support and Treatment After Replacement (STAR) clinical trial. Self-reported neuropathic pain and postoperative pain was assessed at three, nine, and 15 months after surgery using the painDETECT and Douleur Neuropathique 4 (DN4) questionnaires collected by postal survey.Aims
Methods
Dual compartment knee replacement has been introduced to allow sparing of the cruciate ligaments and lateral compartment and preserve some biomechanics of knee function. To study the early clinical and radiographic results of this new prosthesis.Background
Aim
NICE guidelines state patients undergoing elective TKR receive post-operative chemical prophylaxis unless contraindicated, following guideline implementation our aim was to determine VTE incidence and wound complication outcomes related to administration of Rivaroxaban or Enoxaparin. From April to October 2010 we prospectively studied 294 patients having primary or revision TKR. Each received either Rivaroxoban (n=219), Enoxaparin (n=68), UHF 5000 units (n=4) or no thromboprohylaxis (n=3) post-operatively. Primary outcome was identification of symptomatic post-operative VTE incidence and compared incidence over the same period in 2009 when aspirin was the standard chemical prophylaxis for VTE. Secondary outcomes were prolonged wound oozing rates and wound washout. VTE occurred in 3 of 219 patients (2 PE, 1 DVT) receiving Rivaroxaban, and 1 PE in a patient who did not receive any thromboprophylaxis. No patients prescribed Enoxaparin developed VTE. In the same period 2009 there were 21 confirmed PEs in 512 patients undergoing TKR. This was statistically significant (Chi squared test p=0.02). Prolonged oozing was noted in 3 patients receiving Enoxaparin, and 17 patients receiving Rivaroxaban. 6 patients treated with Rivaroxaban returned to theatre, 3 for continuous ooze, 2 for wound dehiscence and 1 for infection. During the same period in 2009, there was only 1 return to theatre for haematoma washout. (Chi squared test; p=0.02). Following the NICE guidelines, there is a reduction in the PE rate following TKR but there is an increase in the overall return to theatre rate.
Involvement of Patellofemoral joint (PFJ) has significant bearing in the management of osteoarthritis of the knee. The aim of this study is to assess the relationship between skyline radiographs, MRI and arthroscopic findings in the patellofemoral joint. Data was collected prospectively from fifty-three patients who underwent arthroscopy. There were 36 males and 17 females in the group with mean age of 48 years (range 18-71). Arthroscopically PFJ arthritis was classified based on Outerbridge grading system. Patients with Outerbridge grade III and IV lesions were considered to have significant arthritis of the PFJ. Kellgren-Lawrence grading system was used to assess the skyline radiographs. Radiographically patients with grade III and IV Kelgren-Lawrence changes were considered to have significant osteoarthritis of the PFJ. MRI scans were also studied to assess involvement of PFJ. Thirty-two patients had MRI scan and 20 patients had skyline views done as part of preoperative work up. Arthroscopic findings were considered as gold standard. MRI scan had specificity of 75%, sensitivity of 81%, positive predictive value of (PPV) 77 and negative predictive value of (NPV) 80% in diagnosing significant PFJ arthritis. Skyline radiographs had specificity of 100%, sensitivity of 50%, PPV of 100% and NPV of 57%. The overall accuracy of skyline radiographs in predicting significant PFJ arthritis was 70% and for MRI was 78%. We conclude that skyline radiographs has some value in he diagnosis of PFJ arthritis, however the sensitivity and negative predictive value is very is poor.
Between December 2004 and June 2006, 136 patients (156 total hip replacements), were sent from the waiting list of the Cardiff Vale NHS Trust to the NHS Treatment Centre, Weston-super-Mare, in an attempt to reduce the waiting time for total hip replacement. Because of concerns about their outcome, each patient was contacted and invited to attend a review appointment with a consultant specialising in hip and revision hip replacement. A total of 98 patients (113 hips) were reviewed after a mean of 23 months (11 to 30). There were 104 cemented hips, seven hybrid and two cementless. An acetabular inclination of >
55° was seen in 18 (16%). Radiolucent lines around the acetabular component were seen in 76 (67%). The femoral component was in more than 4° of varus in 47 (42%). The medial floor had been breached in 13 (12%) and there was a leg-length discrepancy of more than 1 cm in ten (9%). There were three dislocations, one femoral fracture, one pulmonary embolus, one deep infection and two superficial wound infections. To date, 13% (15 hips) have been revised and a further 4% (five hips) await revision, mostly for a painful loose acetabular component. The revision rate far exceeds the 0.5% five-year failure rate reported in the Swedish Registry for the components used. This initiative and the consequent need for correction of the problems created, has significantly increased the workload of our unit.
144 total hip replacements were performed by Swedish Orthopaedic Surgeons at Weston NHS Treatment Centre between 2004–2006, in an attempt to reduce the waiting list in Cardiff. Following concerns regarding the outcome of knee arthroplasty patients, the Welsh Assembly funded a clinical and radiographic review of all hip arthroplasty patients from the same unit. 100 hips were reviewed at a mean follow-up of 24 months. The mean Oxford Hip Score was 30 (range 12–60). Radiolucencies were seen in acetabular zone 1 in 34, and all 3 zones in 28 hips. Femoral component position was >
4 degrees varus in 41 cases. Medial floor breach with intrapelvic cement was seen in 12 cases. 10 cases had >
1cm leg length discrepancy. There were 3 early dislocations, 1 intraoperative distal femoral fracture, 1 Pulmonary Embolus and 2 superficial infections. 4 patients have received further treatment so far, and 12 have been listed for acetabular component revision for loosening. 1 has been listed for stem revision for symptomatic leg length discrepancy of 2.5cm. There is an unacceptably high early failure rate in this group of patients. The cost of further investigation and revision surgery far outweighs cost-savings achieved by outsourcing treatment to a distant centre.
Dissociation of the polyethylene liner of modular acetabular components is a rare occurrence, and previous reports have commented on the difficulty in diagnosis from plain radiographs. The radiograph is often incorrectly reported by radiologists as showing advanced polyethylene wear, causing delay in referral and increasing the complexity of treatment required. We report 9 cases of late polyethylene liner dissociation of the cementless Harris-Galante II porous-coated acetabular component (Zimmer Inc, Warsaw, IN) which occurred without trauma or injury. This is the largest reported series to date. In all cases, there was a common pattern of clinical symptoms and signs which is described. Radiographs showed a distinct appearance with a radiolucency medial to the femoral neck in association with an eccentrically placed femoral head lying in contact with the acetabular metal shell. We have termed this the ‘crescent sign’. We believe that the diagnosis can be made from a single antero-posterior pelvic radiograph without the need for previous films for comparison, or the need for arthrography. Clinicians should look specifically for the crescent sign when an eccentrically placed femoral head has been noted, in order to differentiate the more unusual diagnosis of dissociation from that of polyethylene wear. Early diagnosis and prompt referral prevents further damage to the femoral head and metal acetabular shell, thus reducing the complexity of revision surgery.
There is a strong drive from industry, patients and the media to offer minimal access hip surgery (MAS) for joint arthroplasty. There is a plethora of definitions, implants, specialist instrumentation and techniques available. Confusion reigns as to the definition, who should offer it, which approach should be used, and what training should be undertaken.
Of those with a specialist interest in hip arthroplasty, 37% had performed MAS. Of those performing MAS, 83% had observed another surgeon and 60% had attended a course. 29% of consultants intend to perform MAS in the future. The mean and mode quoted length of a regular total hip arthroplasty scar was 15.4 and 15cm respectively. The mean and mode quoted length of a MAS scar was 9.7 and 10 cm respectively. 75% used the miniposterior approach. Relationships with specialisation, British Hip Society membership and volume breakdown are discussed.
There has been a rapid uptake in the use of Resurfacing Hip Replacement (RHR) in the United Kingdom, and its use is likely to accelerate both in Europe and the USA. The current level of use of RHR is not accurately known. It was decided to audit the use of RHR amongst Consultant Orthopaedic Surgeons in the United Kingdom, and to identify the number of operations performed in the last twelve month period, and the specific training undertaken before offering this procedure. A questionnaire was sent to 1600 Consultant Orthopaedic Surgeons with 894 responding. 19% had performed RHR in the previous year. Excluding surgeons that do not perform Total Hip Replacement, 23.5% of surgeons had performed RHR. 29.5% of all orthopaedic surgeons had observed RHR surgery and 23% had been on an RHR course. 65% of all consultants who had attended a course were offering RHR surgery. 7.8% of those performing RHR had neither been on a course nor observed surgery. There was no relationship between years in practice and RHR surgery. There was a weak association with British Hip Society membership and with a previous fellowship in Hip Surgery. Of those performing RHR, 72% perform less than 20 cases per year. The majority of surgeons perform 6-10 RHRs per year. Although interest in RHR is increasing, it is currently performed by the minority of consultants. Given the steep learning curve, the lack of knowledge of long-term survival, and concerns regarding metal on metal bearing surfaces, RHR should be used by surgeons with a specialist interest in hip arthroplasty. We believe RHR should be used in accordance with the guidance given by the National Institute for Clinical Excellence.
Nine patients underwent arthrodesis of the knee using a customised coupled nail (the Mayday arthrodesis nail), five after infected arthroplasty, one following failed arthrodesis, one for intractable anterior knee pain, one for Charcot instability and one after trauma. Comparison was made with 17 arthrodeses, eight undertaken using external fixation, four with dual compression plates, and five with long Küntscher nails. Union was achieved in all patients (100%) at a mean time of ten months using the customised implant. There were no complications despite early weight-bearing. No further procedures were required. This contrasted with a rate of union of 53% and a complication rate of 76% with alternative techniques. Of this second group, 76% required a further operative procedure. We compared the Mayday arthrodesis nail with other techniques of arthrodesis of the knee. The differences in the need for further surgery and occurrence of complications were statistically significant (p <
0.001), and differences in the rate of nonunion and inpatient stay of less than three weeks were also significant (p <
0.05) using Fisher’s exact test. We conclude that a customised coupled intramedullary nail can give excellent stability allowing early weight-bearing, and results in a high rate of union with minimal postoperative complications.
The aim of this study was to demonstrate the effectiveness of a customised coupled arthrodesis nail. Knee arthrodesis is now infrequently performed and is usually reserved as a salvage for infected Joint arthroplasty or occasionally for intractable pain. Many methods have been used. Recently locked intramedullary coupled nails have gained in popularity. To deal with all size combinations a large inventory is required. We wish to report our series using a customised implant and to compare the outcome with other methods of knee arthrodesis. Nine patients underwent arthrodesis using this implant, six following infected arthroplasty, two for intractable anterior knee pain and following trauma. Comparison was made with 17 arthrodeses performed since 1993 using external fixation (8), plates (4), and long K-nails (5). Union was achieved in nine patients (100%) at a mean time of 10 months using the customised implant. There were no complications despite early weight-bearing. No further procedures were required. This contrasted with a union rate of 65% with a 76% complication rate using alternative techniques. Seventy six percent of this second group required a further operative procedure. We conclude that a customised coupled intramedullary nail can give excellent stability allowing early weight-bearing, and results in a high union rate with minimal post-operative complications. The differences in need for further surgery and occurrence of complications were statistically significant (p<
0.001), and differences in in-patient stay and non-union rate were also significant (p<
0.05) using Fisher’s exact test.